Emerging Indications for Hyperbaric Oxygen Treatment

Starting soon · Phase 4

Conditions studied: Post-COVID-19 Condition, Ulcerative Colitis, Crohn Disease, Calciphylaxis, Frostbite, Acute COVID-19, Pyoderma Gangrenosum, Pterygium, Hypospadias, Head Trauma, Pneumatosis Intestinalis, Ischemic Bowel, Raynaud Syndrome, Malignant Otitis Externa, Nonarteritic Anterior Ischemic Optic Neuropathy, Central Retinal Vein Occlusion, Femoral Head Necrosis, Invasive Fungal Infection, Chronic Anal Fissure, Vasculitic Ulcer, Graft-vs-Host Disease, Decubitus Ulcer, Greater Trochanteric Pain Syndrome, Rectovaginal Fistula, Pouchitis, Tinnitus, Clostridium Enterocolitis, Branch Retinal Artery Occlusion, Axonotmesis, Multiple Sclerosis, Inclusion Body Myositis, Epidermolysis Bullosa (EB), Osteonecrosis, Ulcer Ischemic, Avascular Necrosis of Bone, Prosthesis Related Infections, Facial Filler Injections, Cystitis Chronic, Ligament Injury, Anastomosis, Leaking, Cartilage Injury

In brief

This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.

Key facts

Study ID
NCT07240649
Run by
Jay C. Buckey Jr.
People needed
100
Starts
2026-08-01
Expected to finish
2035-12-01
Last updated by the study team
2026-07-06

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.